Delivery Order SPE2DB22D1202-SPE2DB23FJBL8

Award Date 9/13/23
Potential Completion Date 9/14/23
Potential Value $1K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a firm fixed price delivery order valued at one hundred fifty-three thousand five hundred dollars to Amerisourcebergen Drug Corporation for the supply of five hundred tablets of metformin hydrochloride extended release 750 milligrams. The delivery order was issued against an existing prime vendor contract vehicle and calls for shipment to a facility in Conshohocken, Pennsylvania by June 29, 2023 to support the Agency's medical supply needs....
The Defense Logistics Agency awarded a $768 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 360 tablets of 500mg metformin HCL ER. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The delivery order has a period of performance from September 8-11, 2023. Amerisourcebergen Drug Corporation is a division of Amerisourcebergen Corporation, which will perform as the prime contractor. No subcontractors or set aside designations were...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $13,953.55 to Amerisourcebergen Drug Corporation for the supply of 1,000 metformin hydrochloride extended release 500 mg tablets. Amerisourcebergen Drug Corporation will perform as the prime contractor, with corporate oversight provided by its parent company Amerisourcebergen Corporation. Performance will take place in Conshohocken, Pennsylvania over a one day period from August 28 to August 29, 2023. The delivery...
The Defense Logistics Agency awarded a $576 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 360 tablets of 500mg metformin hydrochloride extended release. The order is to be fulfilled by Amerisourcebergen's Conshohocken, Pennsylvania facility by September 12, 2023. Amerisourcebergen Drug Corporation is a division of AmerisourceBergen Corporation, which will perform as the prime contractor for this order placed under an existing DLA contract vehicle. The Defense...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at one hundred fifty-four dollars and six cents to Amerisourcebergen Drug Corporation for the supply of one thousand metformin hydrochloride extended release 500 milligram tablets. The place of performance is Amerisourcebergen's Conshohocken, Pennsylvania facility. The period of performance is July 6 through July 7, 2023. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the requested...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at fifty thousand two hundred fifty dollars to Amerisourcebergen Drug Corporation for the supply of five hundred tablets of metformin hydrochloride extended release 750 milligrams. The delivery order was issued against an existing indefinite-delivery/indefinite-quantity contract vehicle and requires performance within the one day period of September 7 through 8, 2023. Amerisourcebergen Drug Corporation, a division of...
The Defense Logistics Agency Troop Support Medical awarded a $1,253 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561504624 metformin hydrochloride extended release 500 mg tablets. Under this contract, Amerisourcebergen will deliver 1,000 tablets to a facility in Conshohocken, Pennsylvania by July 17, 2023 to fulfill the agency's requirements. As a major pharmaceutical distributor, Amerisourcebergen supports the DLA's medical supply chain needs through existing...
Amerisourcebergen Drug Corporation has been awarded a $2,448 firm fixed price delivery order against an unidentified contract vehicle to supply 90 tablets of 1,000 mg metformin ER (extended release) gastro-resistant tablets to the Defense Logistics Agency by October 16, 2023. The delivery order was awarded on October 13, 2023 without a set-aside designation by the Defense Logistics Agency located in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corporation's corporate office in Conshohocken...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at fifty-six thousand dollars to Amerisourcebergen Drug Corporation for the supply of one hundred eighty tablets of metformin hydrochloride extended release five hundred milligrams. The single day contract is to be performed by Amerisourcebergen in Conshohocken, Pennsylvania and will conclude on September 8, 2023. As a major supplier of pharmaceuticals to the Department of Defense, Amerisourcebergen will deliver the...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $3,273.80 to Amerisourcebergen Drug Corporation for the supply of 1,000 metformin hydrochloride extended release 500 mg tablets. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the pharmaceutical products from its facility in Conshohocken, Pennsylvania by August 10, 2023 in support of the Defense Logistics Agency's logistics and procurement programs. The parent company, Amerisourcebergen...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB23FJBL8
    Delivery Order

The Defense Logistics Agency awarded a firm fixed price delivery order valued at one thousand twenty dollars to Amerisourcebergen Drug Corporation for the supply of four hundred fifty six thousand two hundred sixteen tablets of one thousand milligram metformin extended release gastro-resistant tablets. The order is to be fulfilled within a single day in September 2023, with performance taking place at Amerisourcebergen's facility in Conshohocken, Pennsylvania. Amerisourcebergen Corporation is the identified parent company for this order placed under an existing DLA pharmaceuticals contract vehicle. No subcontractors or set aside designations are indicated.

Generated 12/24/23, 1:41 PM